Given that c-MafΔTAM mice can survive for at least 2 years following TAM injection (n = 6, data not shown), it is possible that c-Maf loss leads to renal glycosuria, basic aminoaciduria and albuminuria without diabetes, complete FRTS, morphological changes, and life-threatening kidney injuries. The gene discussed is MAF; the disease is diabetes mellitus.